Ilex Medical Ltd (TLV:ILX)

Ilex Medical Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	186.76	177.25	148.38	200.96	259.23	159.83
Short-Term Investments	26.45	25.87	41.25	2.74	-	-
Trading Asset Securities	33.39	33.76	27.48	22	25.52	15.93
Cash & Short-Term Investments	246.61	236.88	217.11	225.7	284.75	175.75
Cash Growth	-5.81%	9.11%	-3.81%	-20.74%	62.02%	101.31%
Accounts Receivable	241.47	249.37	286.25	248.26	219.99	239.46
Other Receivables	6.84	17.56	15.57	3.04	3.73	0.38
Receivables	248.3	266.93	301.82	251.3	223.72	239.84
Inventory	153.23	157.89	159.68	145.8	116.32	136.68
Other Current Assets	27.24	56.77	7.39	12.02	6.93	6.72
Total Current Assets	675.37	718.47	686.01	634.83	631.72	558.99
Property, Plant & Equipment	148.85	155.46	160.91	145.28	151.41	154.78
Long-Term Investments	66.75	53.71	57.95	72.66	32.1	0.45
Goodwill	7.01	7.01	7.01	7.01	-	-
Other Intangible Assets	13.58	17.08	21.27	25.06	25.87	31.69
Long-Term Accounts Receivable	-	34.91	28.51	5.73	3.75	6.42
Long-Term Deferred Tax Assets	6.13	7.42	8.51	6.35	6.35	4.46
Long-Term Deferred Charges	-	-	-	0.04	0.08	0.08
Other Long-Term Assets	29.58	0.01	45.95	2.23	23.8	22.38
Total Assets	947.26	994.07	1,016	899.18	875.07	779.25
Accounts Payable	96.14	120.44	172.11	142.32	124.39	162.79
Accrued Expenses	-	-	-	-	-	40.2
Short-Term Debt	0.1	-	-	-	-	0.22
Current Portion of Long-Term Debt	-	0.31	0.41	0.56	1.13	15.27
Current Portion of Leases	12.88	12.22	11.47	12.28	11.96	8.56
Current Income Taxes Payable	6.27	4.5	1.4	2.22	40.39	7.22
Current Unearned Revenue	-	-	-	-	-	33.4
Other Current Liabilities	103.13	130.4	93.15	68.45	62.23	11.58
Total Current Liabilities	218.53	267.87	278.54	225.83	240.11	279.22
Long-Term Debt	-	-	0.31	0.73	1.29	2.42
Long-Term Leases	33.73	38.81	36.07	37.99	44.36	40.28
Long-Term Unearned Revenue	21.31	25.28	60.33	4.11	-	6.08
Long-Term Deferred Tax Liabilities	1.87	2.55	2.94	3.15	6.72	7.58
Other Long-Term Liabilities	10.5	12.12	12.77	14.28	7.02	0.12
Total Liabilities	286.9	347.58	392.61	286.08	299.49	335.71
Common Stock	12.48	12.48	12.48	12.48	12.48	12.48
Additional Paid-In Capital	150.5	150.5	150.5	150.5	150.5	150.5
Retained Earnings	580.97	568.58	544.92	515.41	472.39	334.63
Treasury Stock	-9.2	-9.2	-9.2	-3.49	-	-
Comprehensive Income & Other	-74.38	-75.86	-75.19	-61.79	-59.79	-54.07
Total Common Equity	660.36	646.49	623.51	613.1	575.57	443.54
Shareholders' Equity	660.36	646.49	623.51	613.1	575.57	443.54
Total Liabilities & Equity	947.26	994.07	1,016	899.18	875.07	779.25
Total Debt	46.72	51.35	48.27	51.55	58.74	66.74
Net Cash (Debt)	199.89	185.53	168.84	174.15	226.02	109.01
Net Cash Growth	-4.14%	9.88%	-3.04%	-22.95%	107.33%	-
Net Cash Per Share	-	16.58	15.09	15.44	20.04	10.22
Filing Date Shares Outstanding	-	11.19	11.28	11.28	11.28	11.28
Total Common Shares Outstanding	-	11.19	11.19	11.25	11.28	11.28
Working Capital	456.84	450.6	407.47	409	391.61	279.77
Book Value Per Share	-	57.78	55.73	54.52	51.02	39.32
Tangible Book Value	639.78	622.4	595.24	581.04	549.7	411.85
Tangible Book Value Per Share	-	55.63	53.20	51.67	48.73	36.51
Land	-	0.06	0.06	0.06	0.06	0.06
Machinery	-	254.19	244.49	212.94	193.36	188.2
Leasehold Improvements	-	17.78	25.19	24.04	25.51	25.36

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.